Form 4: Mesa Laboratories CEO Gary Owens Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4
Gary Owens, President and CEO of Mesa Laboratories, exercised stock options and sold 21,000 shares of common stock on March 19, 2025, according to a pre-arranged Rule 10b5-1 trading plan.
Summary
- On March 19, 2025, Gary Owens, the President and CEO of Mesa Laboratories, exercised a non-qualified stock option for 21,000 shares at a price of $122.98.
- Simultaneously, Owens sold 21,000 shares of Mesa Laboratories' common stock at $123.91 per share.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on September 12, 2024.
- Following these transactions, Owens directly owns 43,337 shares of common stock and 73,769 derivative securities (non-qualified stock options).
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document simply reports stock transactions by an executive under a pre-arranged plan. It doesn't inherently indicate positive or negative news about the company.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. The use of Rule 10b5-1 plans allows insiders to sell shares over a period of time, avoiding concerns about trading on material non-public information.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
- Rule 10b5-1 trading plans are widely used by corporate insiders to manage their stock holdings in a compliant manner.
- The size of the transaction is not significant compared to the overall market capitalization of Mesa Laboratories, but it is important to monitor insider activity for potential trends.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, depending on market perception of insider selling.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 03/20/2017 | Grant date of non-qualified stock options, exercisable 1/7 on each anniversary. |
| 09/12/2024 | Date of adoption of Rule 10b5-1 trading plan. |
| 03/19/2025 | Date of stock option exercise and stock sale. |
| 03/20/2025 | Expiration date of non-qualified stock options. |
| 03/24/2025 | Date of signature on the Form 4 filing. |
Keywords
Mesa Laboratories, Gary Owens, stock options, Rule 10b5-1, insider trading, MLAB, stock sale, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.